Leukocytosis is associated with poor survival but not with increased risk of thrombosis in essential thrombocythemia: a population-based study of 311 patients

被引:37
作者
Girodon, F. [1 ,2 ]
Dutrillaux, F. [1 ]
Broseus, J. [1 ]
Mounier, M. [2 ]
Goussot, V. [1 ]
Bardonnaud, P. [1 ]
Chretien, M. L. [3 ]
Maynadie, M. [1 ,2 ]
机构
[1] CHU Dijon, Hop Bocage, Hematol Lab, Dijon, France
[2] Univ Bourgogne, Registre Hemopathies Malignes Cote Or, Dijon, France
[3] CHU Dijon, Hop Bocage, Serv Hematol Clin, Dijon, France
关键词
PROGNOSTIC-FACTORS; LIFE EXPECTANCY;
D O I
10.1038/leu.2010.5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:900 / 903
页数:5
相关论文
共 11 条
[1]   Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemia [J].
Carobbio, Alessandra ;
Finazzi, Guido ;
Antonioli, Elisabetta ;
Guglielmelli, Paola ;
Vannucchi, Alessandro M. ;
Delaini, Federica ;
Guerini, Vittoria ;
Ruggeri, Marco ;
Rodeghiero, Francesco ;
Rambaldi, Alessandro ;
Barbui, Tiziano .
BLOOD, 2008, 112 (08) :3135-3137
[2]   Long-term outcome of 231 patients with essential thrombocythemia - Prognostic factors for thrombosis, bleeding, myelofibrosis, and leukemia [J].
Chim, CS ;
Kwong, YL ;
Lie, AKW ;
Ma, SK ;
Chan, CC ;
Wong, LG ;
Kho, BCS ;
Lee, HK ;
Sim, JPY ;
Chan, CHN ;
Chan, JCW ;
Yeung, YM ;
Law, M ;
Liang, R .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (22) :2651-2658
[3]   Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients [J].
Gangat, N. ;
Wolanskyj, A. P. ;
McClure, R. F. ;
Li, C-Y ;
Schwager, S. ;
Wu, W. ;
Tefferi, A. .
LEUKEMIA, 2007, 21 (02) :270-276
[4]   Incidence, clinical features and outcome of essential thrombocythaemia in a well defined geographical area [J].
Jensen, MK ;
Brown, PD ;
Nielsen, OJ ;
Hasselbalch, HC .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2000, 65 (02) :132-139
[5]  
Mesa RA, 1999, AM J HEMATOL, V61, P10, DOI 10.1002/(SICI)1096-8652(199905)61:1<10::AID-AJH3>3.0.CO
[6]  
2-I
[7]   Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy [J].
Palandri, Francesca ;
Catani, Lucia ;
Testoni, Nicoletta ;
Ottaviani, Emanuela ;
Polverelli, Nicola ;
Fiacchini, Mauro ;
De Vivo, Antonio ;
Salmi, Federica ;
Lucchesi, Alessandro ;
Baccarani, Michele ;
Vianelli, Nicola .
AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (04) :215-220
[8]   Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia [J].
Passamonti, F ;
Rumi, E ;
Pungolino, E ;
Malabarba, L ;
Bertazzoni, P ;
Valentini, M ;
Orlandi, E ;
Arcaini, L ;
Brusamolino, E ;
Pascutto, C ;
Cazzola, M ;
Morra, E ;
Lazzarino, M .
AMERICAN JOURNAL OF MEDICINE, 2004, 117 (10) :755-761
[9]   Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients [J].
Passamonti, Francesco ;
Rumi, Elisa ;
Arcaini, Luca ;
Boveri, Emanuela ;
Elena, Chiara ;
Pietra, Daniela ;
Boggi, Sabrina ;
Astori, Cesare ;
Bernasconi, Paolo ;
Varettoni, Marzia ;
Brusamolino, Ercole ;
Pascutto, Cristiana ;
Lazzarino, Mario .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (11) :1645-1651
[10]   The interaction between leukocytosis and other risk factors for thrombosis in essential thrombocythemia [J].
Tefferi, Ayalew ;
Gangat, Naseema ;
Wolanskyj, Alexandra .
BLOOD, 2007, 109 (09) :4105-4105